Marshall Wace, LLP Zoetis Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 594,380 shares of ZTS stock, worth $70.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
594,380
Previous 43,184
1276.39%
Holding current value
$70.6 Million
Previous $6.73 Million
1191.49%
% of portfolio
0.1%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding ZTS
# of Institutions
2,088Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...